<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Hexo</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="A billion-plus covid-19 shots in 2021. Can Serum Institute do it?2021年接种10亿次以上covid-19疫苗。印度的血清研究所能做到吗? Racing ahead 前进![image-20210313101123494](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Applicatio">
<meta property="og:type" content="article">
<meta property="og:title" content="Hexo">
<meta property="og:url" content="http://example.com/2021/03/13/Day326-The%20Economist/index.html">
<meta property="og:site_name" content="Hexo">
<meta property="og:description" content="A billion-plus covid-19 shots in 2021. Can Serum Institute do it?2021年接种10亿次以上covid-19疫苗。印度的血清研究所能做到吗? Racing ahead 前进![image-20210313101123494](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Applicatio">
<meta property="og:locale" content="en_US">
<meta property="article:published_time" content="2021-03-13T02:10:20.944Z">
<meta property="article:modified_time" content="2021-03-13T02:11:50.047Z">
<meta property="article:author" content="John Doe">
<meta name="twitter:card" content="summary">
  
    <link rel="alternate" href="/atom.xml" title="Hexo" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Hexo" rel="home"> Hexo </a>
            
          </h1>

          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day326-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2021/03/13/Day326-The%20Economist/" class="article-date">
	  <time datetime="2021-03-13T02:10:20.944Z" itemprop="datePublished">March 13, 2021</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <h1 id="A-billion-plus-covid-19-shots-in-2021-Can-Serum-Institute-do-it"><a href="#A-billion-plus-covid-19-shots-in-2021-Can-Serum-Institute-do-it" class="headerlink" title="A billion-plus covid-19 shots in 2021. Can Serum Institute do it?"></a>A billion-plus covid-19 shots in 2021. Can Serum Institute do it?</h1><p>2021年接种10亿次以上covid-19疫苗。印度的血清研究所能做到吗?</p>
<h6 id="Racing-ahead-前进"><a href="#Racing-ahead-前进" class="headerlink" title="Racing ahead 前进"></a>Racing ahead 前进</h6><p>![image-20210313101123494](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20210313101123494.png) </p>
<h5 id="The-Indian-vaccine-maker-may-account-for-almost-half-the-world’s-supply"><a href="#The-Indian-vaccine-maker-may-account-for-almost-half-the-world’s-supply" class="headerlink" title="The Indian vaccine-maker may account for almost half the world’s supply"></a>The Indian vaccine-maker may account for almost half the world’s supply</h5><p>印度的疫苗制造商可能占世界疫苗供应的近一半</p>
<blockquote>
<p>Mar 3rd 2021 </p>
</blockquote>
<p>ON MARCH 5TH 2020 Mumbai’s horseracing season culminated with the Poonawalla Breeders’ Multimillion, a <strong>day-long</strong> extravaganza dominated by India’s first family of the sport, the Poonawallas. Triumphs at the track were accompanied by news reports on the Bollywood lifestyles of Adar Poonawalla and his wife, Natasha, whom Elle magazine described as “India’s first lady of fabulousness”. Only cursory attention spilled over to the couple’s day job running Serum Institute of India, the press-shy vaccine-maker <strong>at the root of</strong> the family fortune.</p>
<blockquote>
<p>culminate 告终</p>
<p>day-long 整天的</p>
<p>extravaganza  奢华的展示</p>
<p>cursory  草草的</p>
</blockquote>
<p>2020年3月5日，孟买的赛马季以普纳瓦拉赛马者的数百万美元而达到高潮，这是一个由印度第一个马术家族普纳瓦拉主导的为期一天的盛会。赛场上的胜利伴随着关于阿达尔·普纳瓦拉和他的妻子娜塔莎的宝莱坞生活方式的新闻报道，《Elle》杂志称娜塔莎为“印度最美丽的第一夫人”。对于这对夫妇的日常工作——印度血清研究所(Serum Institute of India)——只引起了些许关注。这家不愿被媒体关注的疫苗制造商是家族财富的根源。</p>
<p>A year on it is the company, not its flamboyant owners, that is making headlines. As the covid-19 vaccination drive encounters <strong>production glitches</strong> in Europe, <strong>hits distribution snags</strong> in America and <strong>faces a geopolitical scramble</strong> for supply everywhere, Serum Institute has emerged as the one firm apparently able to <strong>ramp up</strong> production <strong>fast</strong> and export the doses <strong>without courting controversy</strong>. By the end of the year, Mr Poonawalla says, it will <strong>add 1.5bn covid-19 shots</strong> to 1.3bn-1.5bn doses against diseases <strong>from measles to tuberculosis</strong> that it already produces annually. On February 23rd it <strong>dispatched the first mass shipment</strong>, of 70m shots of the Oxford-AstraZeneca vaccine, <strong>to India and two dozen other poor countries in the COVAX vaccine-sharing programme</strong>. On March 1st Canada said it will procure 500,000 doses from the company. <strong>The relatively small family concern</strong>, which entered last year with annual revenues of $735m and a workforce of 6,000, <strong>is becoming mission-critical to the global fight against the coronavirus</strong>.</p>
<blockquote>
<p>flamboyant 炫耀的；艳丽的</p>
<p> glitch 失灵；小故障；小差错</p>
<p>snag 障碍</p>
<p>court 招致</p>
<p>procure 设法获得</p>
<p>concern 公司</p>
</blockquote>
<p>一年过去了，成为头条新闻的是这家公司，而不是其浮夸的所有者。随着covid-19疫苗接种运动在欧洲遭遇生产故障，在美国遭遇分销障碍，并面临各地对供应的地缘政治争夺，血清研究所(Serum Institute)已成为一家显然能够迅速增加生产并出口疫苗而不引发争议的公司。普纳瓦拉表示，到今年年底，它将在现有的每年产生的麻疹和结核病等疾病的13亿至15亿剂基础上，再增加15亿剂covid-19疫苗。2月23日，它向印度和其他24个参与COVAX疫苗共享计划的贫穷国家运送了第一批7000万支牛津-阿斯利康联合开发的疫苗。3月1日，加拿大表示将从该公司采购50万剂疫苗。这家规模相对较小的家庭企业去年进入市场，年收入为7.35亿美元，拥有6000名员工，正成为全球抗击冠状病毒的关键任务。</p>
<p>Mr Poonawalla’s plans are ambitious, <strong>to put it mildly</strong>. He wants to raise monthly production of the Oxford vaccine from the current 60m-70m to 100m by April. That month the company will start <strong>churning out</strong> 40m-50m of a shot developed by Novavax, an American biotechnology firm, <strong>to build up a “large stock” as it undergoes accelerated review by a number of global regulators.</strong> By late summer Serum Institute <strong>expects to be making another vaccine</strong>, by SpyBiotech, a British startup. <strong>In early 2022</strong> it hopes to be producing a <strong>one-dose nasal vaccine</strong> being developed by Codagenix, another American biotech firm.</p>
<blockquote>
<p>to put it mildly 婉转地说</p>
<p>churn out 大量炮制</p>
</blockquote>
<p>委婉地说，普纳瓦拉的计划雄心勃勃。他希望到4月份将牛津疫苗的月产量从目前的6000万到7000万提高到1亿支。本月，该公司将开始大量生产由美国生物技术公司诺瓦瓦克斯(Novavax)研发的4000万- 5000万针疫苗，以便在全球监管机构加速审查的过程中建立起一个“大库存”。到夏末，血清研究所预计将生产另一种疫苗，由英国初创公司SpyBiotech生产。2022年初，该公司有望生产一剂由另一家美国生物技术公司Codagenix开发的一剂鼻腔疫苗。</p>
<p>Mr Poonawalla <strong>estimates that</strong> until rivals’ new capacity comes online in the autumn, his company’s output will <strong>account for</strong> perhaps 40-50% of the world’s supply. Unlike Pfizer, an American drug giant which recently <strong>upped its production goal</strong> from 1.3bn to 2bn doses this year, <strong>Serum Institute’s shots are cheap and do not need to be stored at ultra-low temperatures.</strong> They will inoculate <strong>swathes of</strong> the poor world.</p>
<blockquote>
<p>inoculate 给..接种</p>
</blockquote>
<p>普纳瓦拉先生估计，在竞争对手的新产能在秋季投产之前，他的公司的产量可能会占到世界供应量的40-50%。美国制药巨头辉瑞公司最近将其今年的生产目标从13亿支提高到20亿支，与此不同，血清研究所的疫苗价格低廉，而且不需要在超低温下储存。他们将为贫困国家的大片地区接种疫苗。</p>
<p><strong>Some of the factors behind the company’s rise to prominence,</strong> like the pandemic and scientists’ rapid response to it, <strong>have been beyond its control.</strong> But Serum Institute has also <strong>placed bold bets</strong> that <strong>run counter to</strong> the traditional process of making vaccines, <strong>in which</strong> investments in capacity and distribution <strong>follow years of research</strong>, <strong>then more years of</strong> clinical trials <strong>for safety and efficacy</strong>. <strong>A brief conversation</strong> last April, between Mr Poonawalla and his father Cyrus, Serum Institute’s founder, <strong>resulted in a decision</strong> to start producing the Oxford vaccine <strong>before any clinical trials had begun.</strong></p>
<blockquote>
<p>prominence 显赫</p>
<p>counter 逆向地</p>
<p>run counter to sth 与某事物相违背</p>
<p>capacity 产能</p>
</blockquote>
<p>该公司崛起背后的一些因素，比如大流行和科学家对它的快速反应，已经超出了它的控制范围。但是血清研究所也进行了大胆的押注，这与传统的疫苗生产过程背道而驰。在传统生产过程中，疫苗生产能力和分销的投资要经过多年的研究，然后是更多年的安全性和有效性的临床试验。去年4月，普纳瓦拉和他的父亲赛勒斯(Cyrus)——血清研究所的创始人——进行了一次简短的交谈，最终决定在任何临床试验开始之前就开始生产牛津疫苗。</p>
<p><strong>It is the latest daring coup by the Poonawallas.</strong> In the 1960s Cyrus turned his horse-breeding business into one that used retired steeds as living vessels to create antibody serum <strong>for treatment of</strong> snake bites, tetanus and other scourges. Forty years later his son, who has been chief executive since 2011, has added 165 countries as customers (often while courting Natasha on holidays). <strong>International sales now account for 70% of the firm’s total</strong>. In December Serum Institute <strong>released the first vaccine</strong> to <strong>be fully developed in</strong> India, against <strong>a variant of pneumonia</strong> which kills 68,000 Indian children a year.</p>
<blockquote>
<p>coup 政变；突然的成功之举</p>
<p>tetanus 破伤风</p>
<p>scourge 祸害</p>
</blockquote>
<p>这是普纳瓦拉家族最近一次大胆的政变。在20世纪60年代，赛勒斯把他的马养殖业变成了用退役的马作为活的容器来制造抗体血清，用于治疗蛇咬伤、破伤风和其他疾病。40年后，他的儿子(自2011年起担任该公司首席执行官)增加了165个国家的客户(通常是在节假日追求娜塔莎的时候)。国际销售现在占公司总销售额的70%。12月，血清研究所发布了首个在印度完全开发的疫苗，用于治疗一种每年导致68000名印度儿童死亡的肺炎变体。</p>
<p><strong>The company’s initial investment</strong> of $80m in capacity to produce the untested Oxford shot <strong>came from its billionaire owners’ own pocket</strong>—<strong>a tidy sum</strong> next to the previous year’s $46m <strong>in capital expenditure.</strong> Since then Serum Institute has received a further $800m: $270m from the Poonawallas, $300m from the Bill &amp; Melinda Gates Foundation, <strong>the world’s biggest charity</strong>, <strong>and the rest from prepayments</strong> by governments, including those of Bangladesh and Morocco.</p>
<blockquote>
<p>tidy 相当大的</p>
<p>prepayment 预先支付</p>
</blockquote>
<p>该公司最初投资8000万美元用于生产未经测试的牛津疫苗，这笔投资来自其亿万富翁所有者自己的腰包，这一数额相当可观，仅次于上一年4600万美元的资本支出。自那以后，血清研究所又获得了8亿美元的资助：来自Poonawallas的2.7亿美元，来自世界最大的慈善机构比尔和梅琳达·盖茨基金会的3亿美元，其余来自政府的预付款，包括孟加拉国和摩洛哥政府的预付款。</p>
<p><strong>The privately held firm will not say how much of that money has already been deployed.</strong> But Mr Poonawalla says it has <strong>doubled production capacity</strong>. It could do this quickly, he adds, thanks to a strategy of installing “<strong>excess capacity ahead of demand</strong>”. For decades it had been adding a new building each year; one that was ready to go <strong>shortly before the fateful chat between father and son</strong> was immediately repurposed for the covid-19 effort.</p>
<blockquote>
<p>shortly before ..之前</p>
</blockquote>
<p>这家私人控股的公司不愿透露这笔资金已经动用了多少。但浦纳瓦拉表示，该公司已将产能翻了一番。他补充道，得益于采取“产能过剩，需求不足”的战略，它才可以迅速做到这一点。几十年来，它每年都要增加一座新建筑; 在父子之间的决定性谈话前不久，一座已经准备就绪的建筑立即被重新用于covid-19的研制。</p>
<p><strong>A long-standing collaboration with</strong> Oxford and Novavax <strong>as part of an effort to create a malaria vaccine</strong> allowed Serum Institute to <strong>secure their recipes early</strong>. <strong>Deep relationships with suppliers of everything from glass vials to expensive “bioreactors” for the production of biological substances have helped smooth procurement.</strong> Serum Institute has hired 1,000 new employees, <strong>increasing its workforce</strong> by a sixth. Another 500 construction workers are putting up new buildings with higher production capacity to add to the 30 or so that the company has erected over the years.</p>
<p>血清研究所与牛津大学和诺瓦瓦克斯公司的长期合作是创造疟疾疫苗努力的一部分，这使得血清研究所能够尽早获得他们的配方。从玻璃小瓶到昂贵的用来生产生物物质的“生物反应器”，与各种供应商的深厚关系帮助采购顺利进行。血清研究所已经雇佣了1000名新员工，员工人数增加了六分之一。另外500名建筑工人正在建造产能更高的新建筑，以增加该公司多年来已建成的30多座建筑。</p>
<p><strong>At the current pace</strong>, Mr Poonawalla thinks, it will take at least two years for the global supply of covid-19 jabs to <strong>meet demand</strong>. It could take less if the world’s regulators <strong>co-ordinated more closely for the duration of the crisis</strong>, he ventures. <strong>Until then</strong> Serum Institute expects to be selling the jabs <strong>more or less at cost</strong>, which means about $3-5 a dose for the Oxford vaccine. <strong>After that, margins will eventually rise. “This situation will last for a long time and there will be future demand,”</strong> Mr Poonawalla predicts. Covid-19 <strong>looks certain to become endemic</strong> in many parts of the world, with annual vaccination <strong>drives akin to</strong> those for influenza <strong>becoming the norm</strong>. His firm’s output will peak at 600m-700m doses a year for each of the four vaccines <strong>it is currently eyeing</strong>, he says.</p>
<blockquote>
<p>venture 大胆说出</p>
<p>akin 类似的</p>
<p>influenza 流感</p>
</blockquote>
<p>浦纳瓦拉认为，按照目前的速度，全球covid-19疫苗供应至少需要两年时间才能满足需求。他认为，如果全球监管机构能在危机期间更紧密地协调一致，可能需要的时间会更少。在此之前，血清研究所预计将以成本价出售这种疫苗，这意味着牛津疫苗每剂约3-5美元。在那之后，利润率最终会上升。普纳瓦拉预测:“这种情况将持续很长一段时间，未来还会有需求。” Covid-19似乎肯定会在世界许多地方成为地方性流行疾病，与流感疫苗接种类似的年度接种活动将成为常态。他说，他的公司目前正在关注的四种疫苗的产量将达到每年6 -7亿剂的峰值。</p>
<p><strong>The pandemic will leave vaccine-making more prominent than ever before</strong>, Mr Poonawalla believes—<strong>and much more crowded</strong>. This will <strong>inject competition into</strong> what most drugmakers consider a thankless volume business <strong>with considerable capital outlays</strong>. A fire earlier this year at one new building <strong>sent a shudder down the spines of the world’s covid-responders</strong> until the company assured them that <strong>the accident</strong>, which affected a production line for a tuberculosis jab, <strong>will not hurt the pandemic effort. Although the bet on</strong> the Oxford vaccine <strong>has paid off</strong>, <strong>and the one on</strong> Novavax <strong>looks likely to</strong>, Codagenix and SpyBiotech <strong>are not yet shoo-ins</strong>. And vaccine nationalism could stymie exports from India or imports of ingredients and kit.</p>
<blockquote>
<p>thankless  吃力不讨好的</p>
<p>spine 脊柱</p>
<p>It sent shivers up and down my spine.</p>
<p>这使我后背直冒凉气。</p>
<p>shoo-in 稳操胜券者；十拿九稳的事</p>
<p>stymie 阻碍</p>
</blockquote>
<p>浦纳瓦拉相信，流感大流行将使疫苗制造比以往任何时候都更加突出，也更加拥挤。这将为这个在大多数制药商看来是吃力不讨好、资本投入巨大的业务注入竞争。今年早些时候，一座新大楼发生火灾，令全球的covid- 19急救人员心惊胆战，直到该公司向他们保证，影响到一条注射结核病疫苗生产线的事故不会影响大流行的努力。尽管对牛津疫苗的押注已经获得了回报，Novavax的押注看起来也很有可能获得回报，但Codagenix和SpyBiotech还没有稳赢。疫苗民族主义可能会阻碍印度的出口或原料和试剂盒的进口。</p>
<p>Mr Poonawalla <strong>nevertheless remains confident</strong> that his firm will <strong>maintain its leading position</strong>. <strong>In contrast to</strong> big pharma, which spends billions on marketing costly medicines, it sells its vaccines <strong>chiefly to</strong> national health authorities, which <strong>prize low prices and reliable supply above all</strong>. <strong>Those have always been</strong> Serum Institute’s <strong>strong suits</strong>. And the Indian company’s <strong>remarkable response t</strong>o covid-19 has <strong>bought it more global goodwill</strong> than any advertising campaign could hope to. ■</p>
<blockquote>
<p> chiefly 首要地</p>
<p>goodwill 商誉</p>
</blockquote>
<p>然而，浦纳瓦拉仍然相信他的公司将保持领先地位。与那些花费数十亿美元销售昂贵药品的大型制药公司不同，该公司的疫苗主要销售给国家卫生部门，而国家卫生部门最看重的是低廉的价格和可靠的供应。这一直是血清研究所的强项。这家印度公司应对新冠肺炎的出色反应为其赢得了比任何广告活动都更大的全球商誉。■</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/03/14/Day327-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2021/03/12/Day325-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#A-billion-plus-covid-19-shots-in-2021-Can-Serum-Institute-do-it"><span class="nav-number">1.</span> <span class="nav-text">A billion-plus covid-19 shots in 2021. Can Serum Institute do it?</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#Racing-ahead-%E5%89%8D%E8%BF%9B"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">Racing ahead 前进</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#The-Indian-vaccine-maker-may-account-for-almost-half-the-world%E2%80%99s-supply"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">The Indian vaccine-maker may account for almost half the world’s supply</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Hexo All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
